Madame Bioscience PCL

Madame Bioscience PCL maintains a conservative capital structure with a debt-to-equity ratio of 0.33, indicating a relatively low reliance on debt financing [doc:valuation snapshot]. The company's liquidity position is characterized as medium risk, with a current ratio of 1.22, suggesting it can cover its short-term liabilities but with limited buffer [doc:valuation snapshot]. Free cash flow of 99.2 million THB supports operational flexibility, though net cash is negative after subtracting total debt, signaling potential refinancing needs [doc:risk assessment]. Profitability metrics show a return on equity of 6.11% and a return on assets of 3.48%, both below the industry median for food products companies, indicating suboptimal capital efficiency [doc:valuation snapshot]. Operating income of 82.6 million THB reflects a 5.6% margin, which is in line with the industry average but leaves room for improvement in cost control [doc:financial snapshot]. The company's revenue is distributed across three segments: Packaging, Food, and Other. The Food segment is the largest contributor, with a diversified product portfolio including frozen food, plant-based food, and processed meat. However, the company's geographic exposure is concentrated in Thailand, with no material international revenue disclosed, which could limit growth potential [doc:financial snapshot]. Outlook for the current fiscal year indicates a modest revenue growth trajectory, supported by stable demand in the frozen and processed food markets. The company's capital expenditure of -44.28 million THB suggests a focus on cost optimization rather than expansion, which may constrain long-term growth [doc:financial snapshot]. Analyst estimates for the last actual revenue of 273.69 million THB align with the company's reported figures, indicating a stable but non-accelerating revenue trend [doc:IR observations]. Risk factors include liquidity constraints and the potential for dilution, though the latter is currently assessed as low. The company's net cash position is negative after subtracting total debt, which could necessitate future financing activities. No recent dilutive events have been disclosed, and the dilution potential remains minimal for now [doc:risk assessment]. Recent filings and transcripts do not highlight any material events or strategic shifts. The company's focus remains on its core food and packaging businesses, with no significant new product launches or market expansions disclosed in the latest reports [doc:financial snapshot].